483
Andre Kalil, M.D.Andre Kalil, M.D. – FDA 483, Jan 14, 2022
Record Details
Andre C. Kalil, M.D., Clinical Investigator, was inspected in Omaha, NE, and cited for multiple deficiencies related to clinical trial conduct. The inspection revealed significant issues with informed consent procedures, including failure to obtain consent, providing consent in the wrong language, and improper documentation. Additionally, the investigator failed to provide adequate oversight of study staff and maintain accurate case histories.
View Company Profile
ID · 7bf08e2b-f585-4584-8ed6-665ac26e0c25
Other documents for Andre Kalil, M.D.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.